|
[1]
|
Liu ZZ, Feng YY, Zhang LL, et al. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution[J]. Cancer Chemother Pharmacol, 2013, 71(5): 1131-1139. |
|
[2]
|
McClements DJ. Advances in fabrication of emulsions with enhanced functionality using structural design principles[J]. Curr Opin Colloid Interf Sci, 2012, 17(5): 235-245. |
|
[3]
|
Groves MJ. The redistribution of bulk aqueous phase phospholipids during thermal stressing of phospholipid-stabilized emulsions[J]. Pharm Pharmacol, 1993, 45(7): 592. |
|
[4]
|
Morais JM, Burgess DJ. Long acting injections and implants: micro-and nano-emulsions (controlled release parenteral drug delivery systems)[M].London: Springer, 2012: 221-238. |
|
[5]
|
Yue PF, Lu XY, Liao MX, et al. The effect of oil components and homogenization conditions on the physicochemical properties of zedoary turmeric oil submicron emulsions[J]. J Dispers Sci Technol, 2010, 31(11):1535-1540. |
|
[6]
|
Patel R, Joshi J. An overview on nanoemulsion: a novel approach[J]. Int J Pharml Sci Res, 2012, 3(12): 4640-4650. |
|
[7]
|
Bague S, Philips B, Rabinovich-Guilatt L, et al. Ophthalmic oil-in-water type emulsion with stable zeta potential[P].USA WO2006050838 A2, 2005-10-10. |
|
[8]
|
Akkar A, Muller RH. Intravenous itraconazole emulsions produced by SolEmuls technology[J]. Eur J Pharm Biopharm, 2003, 56(1): 29-36. |
|
[9]
|
Müller RH, Schmidt S, Buttle I, et al. SolEmuls®-novel technology for the formulation of i.v. emulsions with poorly soluble drugs[J]. Int J Pharm, 2004, 269(2): 293-302. |
|
[10]
|
Yue PF, Li FQ, Liao MX, et al. Process optimization, characterization, and release study in vitro of an intravenous puerarin lipid micropheres loaded with the phospholipid complex[J]. J Dispers Sci Technol, 2011, 32(1): 1-10. |
|
[11]
|
Yue PF, Zheng Q, Wu B, et al. Application of plackett-burman design and box-behnken design to achieve process optimization for geniposide submicron emulsion[J]. J Dispers Sci Technol, 2012, 33(2): 213-222. |
|
[12]
|
Ma YQ, Li G, Xu JH, et al. Combination of submicroemulsion and phospholipid complex for novel delivery of ursodeoxycholic acid[J]. Pharm Dev Technol,2014,19(3):363-372. |
|
[13]
|
Gulati Neha, Gupta Himanshu. Parenteral drug delivery: a review[J]. Recent Patent Drug Deliv Form, 2011, 5(2): 133-145. |
|
[14]
|
Yamamura K, Nakao M, Yano K, et al. Stability of forskolin in lipid emulsions and oil/water partition coefficients[J]. Chem Pharm Bull,1991, 39(4):1032-1034. |
|
[15]
|
Bhalerao AV, Singh SS. In situ gelling ophthalmic drug delivery system for glaucoma[J]. Int J Pharm Biosci, 2011, 2(2): 7-14. |
|
[16]
|
Patel Y, Poddar A, Sawant K. Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability[J]. J Pharm Bioallied Sci, 2012, 4(1): S4-S5. |
|
[17]
|
Ammar H, Salama H, Ghorab M, et al. Nanoemulsion as a potential ophthalmic drug delivery system for Dorzolamide hydrochloride[J]. AAPS Pharm Sci Tech, 2009, 10(3): 808-819. |
|
[18]
|
Gan L, Wang J, Jiang M, et al.Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers[J]. Drug Discov Today, 2013, 18(5-6): 290-297. |
|
[19]
|
Lu Y, Qi J, Wu W. Absorption, disposition and pharmacokinetics of nanoemulsions[J]. Curr Drug Metab,2012, 13(4): 418-428. |
|
[20]
|
Sultana Y, Maurya DP, Iqbal Z,et al. Nanotechnology in ocular delivery: current and future directions[J]. Drugs Today, 2011, 47(6): 441-455. |
|
[21]
|
Zhang N, Zhang Q, Chu T, et al. Formulation optimization of prostaglandin E1-loaded lipid emulsion: enhanced stability and reduced biodegradation[J]. Pharm Dev Tech, 2013, 18(4): 804-812. |
|
[22]
|
GaoY, Xu PF, Chen LL, Li YP. Prostaglandin E1 encapsulated into lipid nanoparticles improves its anti-inflammatory effect with low side-effect[J]. Int J Pharm, 2010, 387(1-2): 263-271. |
|
[23]
|
Ueki R, Tanimoto M, Tatara T, et al. Emulsion of flurbiprofen axetil reduces propofol injection pain due to a decrease in free propofol concentration[J]. J Anesth, 2007, 21 (3): 325-329. |
|
[24]
|
Shen J, Gan L, Zhu C, et al. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect[J]. Int J Pharm, 2011, 412(1-2):115-122. |
点击查看大图
下载:
